Literature DB >> 6608427

Enhanced interleukin activity following asbestos inhalation.

D P Hartmann, M M Georgian, Y Oghiso, E Kagan.   

Abstract

Asbestos inhalation can cause pulmonary fibrosis and is associated with a variety of immunological abnormalities. The purpose of this study was to evaluate the effects of asbestos inhalation on interleukin-1 (IL-1) and interleukin-2 (IL-2) production in a rodent model. Two groups of rats were exposed, by intermittent inhalation, to either amphibole (crocidolite) or serpentine (chrysotile) asbestos. A third (control) group of rats was sham exposed to clean air. Animals from the three exposure groups were thereafter immunized (or not immunized) with fetal calf serum antigens. In order to assay interleukin activity, supernatants were generated from cultures containing alveolar macrophages and autologous splenic lymphocytes, and from cultures containing alveolar macrophages alone. Using assay systems designed to detect IL-1 and IL-2 functional activity, the supernatants were evaluated for their capacity to stimulate lymphoproliferation and fibroblast DNA synthesis. Macrophage-lymphocyte co-culture supernatants, when obtained from immunized, asbestos exposed rats, contained greater IL-1 and IL-2 activity than identical supernatants from immunized, sham exposed animals. These between group differences were not, however, observed in supernatants from unimmunized rats, or when supernatants were generated in the absence of immune lymphocytes. These observations suggest that asbestos exposure is associated with enhanced activation of lymphocytes by antigens. The possible relevance of these findings to asbestos related fibrogenesis and immunological stimulation is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608427      PMCID: PMC1535921     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Manifestations of cellular immunity in the rat after prolonged asbestos inhalation. I. Physical interactions between alveolar macrophages and splenic lymphocytes.

Authors:  K Miller; Z Weintraub; E Kagan
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Immune adherence reactivity of rat alveolar macrophages following inhalation of crocidolite asbestos.

Authors:  K Miller; E Kagan
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

3.  Immunology and asbestosis.

Authors:  M Turner-Warwick
Journal:  Proc R Soc Med       Date:  1973-09

4.  Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes.

Authors:  P Davies; A C Allison; J Ackerman; A Butterfield; S Williams
Journal:  Nature       Date:  1974-10-04       Impact factor: 49.962

5.  Activity of a macrophage factor in collagen formation by silica.

Authors:  A G Heppleston; J A Styles
Journal:  Nature       Date:  1967-04-29       Impact factor: 49.962

6.  Autoantibodies and serum immunoglobulin levels in asbestos workers.

Authors:  A Lange; R Smolik; W Zatoński; J Szymańska
Journal:  Int Arch Arbeitsmed       Date:  1974-01-31

7.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

8.  Physical and chemical characteristics of UICC reference samples.

Authors:  R E Rendall
Journal:  IARC Sci Publ       Date:  1980

9.  Macrophage-T cell interactions involving Listeria monocytogenes--role of the H-2 gene complex.

Authors:  A G Farr; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

10.  Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes.

Authors:  D S Weinberg; E R Unanue
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

View more
  12 in total

Review 1.  Polyclonal activators in pulmonary immune disease.

Authors:  W F Willoughby; J B Willoughby; G F Gerberick
Journal:  Clin Rev Allergy       Date:  1985-05

2.  Immunological consequences of asbestos exposure.

Authors:  D P Hartmann
Journal:  Surv Immunol Res       Date:  1985

3.  Immunomodulation in mineral dust-exposed lungs: stimulatory effect and interleukin-1 release by neutrophils from quartz-elicited alveolitis.

Authors:  Y Kusaka; R T Cullen; K Donaldson
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

4.  Antibody producing cells in the spleens of mice treated with pathogenic mineral dust.

Authors:  S Szymaniec; D M Brown; M Chladzynska; E Jankowska; H Polikowska; K Donaldson
Journal:  Br J Ind Med       Date:  1989-10

5.  Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma.

Authors:  L S Manning; M R Davis; B W Robinson
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

6.  Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis.

Authors:  N Shijubo; K Imai; S Aoki; M Hirasawa; H Sugawara; H Koba; M Tsujisaki; T Sugiyama; Y Hinoda; A Yachi
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

7.  The production of TNF-alpha and IL-1-like activity by bronchoalveolar leucocytes after intratracheal instillation of crocidolite asbestos.

Authors:  X Y Li; D Lamb; K Donaldson
Journal:  Int J Exp Pathol       Date:  1993-08       Impact factor: 1.925

Review 8.  The inorganic dust pneumoconioses.

Authors:  R P Stankus; J E Salvaggio
Journal:  Clin Rev Allergy       Date:  1985-05

9.  Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat.

Authors:  S Tanaka; N Choe; D R Hemenway; S Zhu; S Matalon; E Kagan
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

10.  Time course of gene expression of inflammatory mediators in rat lung after diesel exhaust particle exposure.

Authors:  K Murali Krishna Rao; Jane Y C Ma; Terence Meighan; Mark W Barger; Donna Pack; Val Vallyathan
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.